Abstract
This chapter describes procedural aspects for development of ribozymes in general, and specifically, that cleave mRNA to an essential cellular gene, the AC40 subunit of RNA pol I. Ribozyme design includes functional selection of binding sites followed by computer modeling. These ribozymes are being used in vectors that target expression to the prostate via tissue specific promoters (Voeks, Norris, and Clawson, 1998) and have demonstrated efficacy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 293-301 |
| Number of pages | 9 |
| Journal | Advances in experimental medicine and biology |
| Volume | 465 |
| State | Published - 2000 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
All Science Journal Classification (ASJC) codes
- General Biochemistry, Genetics and Molecular Biology
Fingerprint
Dive into the research topics of 'Design and testing of ribozymes for cancer gene therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver